DARIFENACIN

Week 2

BRAND/GENERIC: Enablex

CLASSIFICATION: Urinary Antispasmodic

INDICATION: Overactive bladder

DOSAGE FORMS: Oral Extended-Release Tablet

DOXAZOSIN

Week 2

BRAND/GENERIC: Cardura, Cardura XL, various

CLASSIFICATION: α₁-Adrenegic Blocker

INDICATION: Benign prostatic hyperplasia, hypertension 

DOSAGE FORMS: Tablet, Tablet (Extended Release)

DUTASTERIDE

Week 2 

BRAND/GENERIC: Avodart

CLASSIFICATION: 5α-Reductase Inhibitor

INDICATION: Benign Prostatic hyperplasia

DOSAGE FORMS: Oral Capsule

FINASTERIDE 

Week 2

BRAND/GENERIC: Proscar, Various

CLASSIFICATION: 5α Reductase Inhibitor

INDICATION: Benign prostatic hyperplasia, male pattern alopecia

DOSAGE FORMS: Oral Tablet

SILDENAFIL 

Week 2

BRAND/GENERIC: Viagra

CLASSIFICATION: Erectile Dysfunction Agent

INDICATION: Erectile Dysfunction, pulmonary hypertension 

DOSAGE FORMS: Oral Tablet 

SOLIFENACIN

Week 2

BRAND/GENERIC: Vesicare

CLASSIFICATION: Urinary Antispasmodic 

INDICATION: Overactive bladder 

DOSAGE FORMS: Oral tablet

TAMSULOSIN

Week 2

BRAND/GENERIC: Flomax, Various

CLASSIFICATION: α₁-Adrenergic Blocker

INDICATION: Benign prostatic hyperplasia

DOSAGE FORMS: oral capsule

TERAZOSIN

Week 2

BRAND/GENERIC: Hytrin, Various

CLASSIFICATION: α₁-Adrenergic blocker

INDICATION: Benign prostatic hyperplasia, hypertension

DOSAGE FORMS: capsule

TOLTERODINE

Week 2

BRAND/GENERIC: Detrol, Detrol LA

CLASSIFICATION: Antimuscarinic

INDICATION: Bladder muscel dysfunction

DOSAGE FORMS: Tablet, Capsule (Extended Release)

VARDENAFIL

Week 2 

BRAND/GENERIC: Levitra, Staxyn

CLASSIFICATION: Phosphodiesterase Type 5 Inhibitor, Erectile Dysfunction Agent

INDICATION: Erectile Dysfunction 

DOSAGE FORMS: Oral Tablet, Oral Tablet Disintigrating

TADALAFIL

Week 2 

BRAND/GENERIC: Cialis

CLASSIFICATION: Phosphodiesterase Type 5 Inhibitor 

INDICATION: Erectile Dysfunction 

DOSAGE FORMS: Oral Tablet, Oral Tablet Disintigrating